The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2024

Filed:

May. 29, 2020
Applicant:

Spinalcyte, Llc, Houston, TX (US);

Inventors:

Pete O'Heeron, Houston, TX (US);

Thomas Ichim, San Diego, CA (US);

Assignee:

SPINALCYTE, LLC, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/33 (2015.01); A61K 9/00 (2006.01); A61K 35/17 (2015.01); C12N 5/077 (2010.01);
U.S. Cl.
CPC ...
A61K 35/33 (2013.01); A61K 35/17 (2013.01); C12N 5/0656 (2013.01); A61K 9/0019 (2013.01); C12N 2502/1114 (2013.01);
Abstract

Disclosed are compositions and methods of treating muscular dystrophies, including Duchenne Muscular Dystrophy (DMD) through administration of fibroblasts and modified fibroblasts systemically and locally. In certain embodiments, fibroblast cells are utilized for replacement of dystrophin through fusion and/or other means of horizontal gene transfer. In other embodiments, the disclosure teaches the use of fibroblasts for reduction of inflammatory reactions and/or immunological reactions which propagate and enhance myodestructive aspects of Duchenne Muscular Dystrophy. In other embodiments, fibroblasts are utilized as vectors for gene therapy and/or gene modifications approaches.


Find Patent Forward Citations

Loading…